These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 12884642)

  • 1. [Torasemide (Trifas) in clinical practice--own experience].
    Grajewska M; Sulikowska B; Manitius J
    Przegl Lek; 2003; 60(1):24-6. PubMed ID: 12884642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefits and risks of torasemide in congestive heart failure and essential hypertension.
    Brater DC
    Drug Saf; 1996 Feb; 14(2):104-20. PubMed ID: 8852525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single dose comparison of torasemide and furosemide in patients with advanced renal failure.
    Klütsch K; Grosswendt J; Haecker W
    Arzneimittelforschung; 1988 Jan; 38(1A):200-4. PubMed ID: 3285834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Torasemide. A review of its pharmacological properties and therapeutic potential.
    Friedel HA; Buckley MM
    Drugs; 1991 Jan; 41(1):81-103. PubMed ID: 1706990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of efficacy and tolerance of different oral doses of torasemide and furosemide in patients with advanced chronic renal failure.
    Kult J; Häcker W; Glocke M
    Arzneimittelforschung; 1988 Jan; 38(1A):212-4. PubMed ID: 3285837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of diuretics in acute and chronic renal failure. Focus on torasemide.
    Risler T; Krämer B; Müller GA
    Drugs; 1991; 41 Suppl 3():69-79. PubMed ID: 1712716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Torasemide, a new potent diuretic. Double-blind comparison with furosemide.
    Broekhuysen J; Deger F; Douchamps J; Ducarne H; Herchuelz A
    Eur J Clin Pharmacol; 1986; 31 Suppl():29-34. PubMed ID: 3536530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of prolonged-release torasemide versus furosemide on myocardial fibrosis in hypertensive patients with chronic heart failure: a randomized, blinded-end point, active-controlled study.
    TORAFIC Investigators Group
    Clin Ther; 2011 Sep; 33(9):1204-1213.e3. PubMed ID: 21906812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Torasemide, a new loop diuretic, in patients with chronic renal failure.
    Russo D; Gazzotti RM; Testa A
    Nephron; 1990; 55(2):141-5. PubMed ID: 2194134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Torasemide in advanced renal failure.
    Kindler J
    Cardiovasc Drugs Ther; 1993 Jan; 7 Suppl 1():75-80. PubMed ID: 8435381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-dependent salidiuretic efficacy of torasemide in comparison to furosemide and placebo in advanced renal failure.
    Mourad G; Haecker W; Mion C
    Arzneimittelforschung; 1988 Jan; 38(1A):205-8. PubMed ID: 3285835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacy of torasemide, a new diuretic agent, in patients with acute heart failure: a double blind comparison with furosemide.
    Stroobandt R; Dodion L; Kesteloot H
    Arch Int Pharmacodyn Ther; 1982 Nov; 260(1):151-8. PubMed ID: 6762167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Torasemide (LUPRAC): a review of its pharmacological and clinical profile].
    Kido H; Ohtaki Y
    Nihon Yakurigaku Zasshi; 2001 Aug; 118(2):97-105. PubMed ID: 11530685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term diuretic treatment in heart failure: are there differences between furosemide and torasemide?].
    Spannheimer A; Müller K; Falkenstein P; Reitberger U; Gutzwiller F; Follath F
    Praxis (Bern 1994); 2002 Sep; 91(37):1467-75. PubMed ID: 12360682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of torasemide on haemodynamic and neurohormonal stress, and cardiac remodelling in heart failure - TORNADO: a study protocol for a randomized controlled trial.
    Balsam P; Ozierański K; Tymińska A; Główczyńska R; Peller M; Fojt A; Cacko A; Sieradzki B; Bakuła E; Markulis M; Kowalik R; Huczek Z; Filipiak KJ; Opolski G; Grabowski M
    Trials; 2017 Jan; 18(1):36. PubMed ID: 28114980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Torasemide in patients with chronic heart failure. Results of clinical administration in general practice].
    Wittig T; Medert G
    Fortschr Med; 1996 Jan; 114(3):24-8. PubMed ID: 8851785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TORAFIC study protocol: torasemide prolonged release versus furosemide in patients with chronic heart failure.
    Díez J; Coca A; de Teresa E; Anguita M; Castro-Beiras A; Conthe P; Cobo E; Fernández E;
    Expert Rev Cardiovasc Ther; 2009 Aug; 7(8):897-904. PubMed ID: 19673667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Torasemide in chronic heart failure: results of the TORIC study.
    Cosín J; Díez J;
    Eur J Heart Fail; 2002 Aug; 4(4):507-13. PubMed ID: 12167392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacokinetics and pharmacodynamics of torasemide.
    Knauf H; Mutschler E
    Clin Pharmacokinet; 1998 Jan; 34(1):1-24. PubMed ID: 9474471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of various diuretics on cardiac function in rats with heart failure].
    Tanaka H; Watanabe K; Harima M; Thanikachalam PV; Yamaguchi K; Tachikawa H; Kodama M; Aizawa Y
    Yakugaku Zasshi; 2009 Jul; 129(7):871-9. PubMed ID: 19571523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.